Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Kanzhun
BZ
$7.27B
| $7.27M | ﹤0.01% |
202,007
+123,608
| +158% | +$4.37M |
|
|
UXIN
2402
Uxin Ltd
UXIN
$306M
| $7.26M | ﹤0.01% |
26,301
+17,266
| +191% | +$5.7M |
|
|
FLNA
2403
Filana Therapeutics
FLNA
$48.8M
| $7.25M | ﹤0.01% |
116,851
+72,936
| +166% | +$6.09M |
|
|
DADA
2404
DELISTED
Dada Nexus
DADA
| $7.25M | ﹤0.01% |
361,920
+298,019
| +466% | +$6.75M |
|
2405
First Trust NASDAQ Cybersecurity ETF
CIBR
$14.4B
| $7.25M | ﹤0.01% |
+148,854
| New | +$7.36M |
|
|
ANZUU
2406
DELISTED
Anzu Special Acquisition Corp I Units
ANZUU
| $7.25M | ﹤0.01% |
733,120
-86,289
| -11% | -$855K |
|
2407
CALL
Royalty Pharma
RPRX
$25.9B
| $7.23M | ﹤0.01% |
200,000
+60,000
| +43% | +$2.33M |
|
2408
Phibro Animal Health
PAHC
$1.47B
| $7.21M | ﹤0.01% |
334,954
+296,811
| +778% | +$7.14M |
|
2409
Photronics
PLAB
$1.79B
| $7.21M | ﹤0.01% |
529,153
+35,447
| +7% | +$481K |
|
2410
CALL
Halliburton
HAL
$26.9B
| $7.21M | ﹤0.01% |
333,300
-361,700
| -52% | -$7.41M |
|
2411
Aspen Aerogels
ASPN
$384M
| $7.2M | ﹤0.01% |
156,510
-286,251
| -65% | -$11.3M |
|
2412
Keros Therapeutics
KROS
$199M
| $7.2M | ﹤0.01% |
181,876
+64,961
| +56% | +$2.31M |
|
|
LFG.WS
2413
CALL
DELISTED
Archaea Energy Inc. Warrants, exercisable for one share of Class A common stock at an exercise price
LFG.WS
| $7.19M | ﹤0.01% |
+980,000
| New | +$7.73M |
|
2414
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $7.19M | ﹤0.01% |
136,680
-66,035
| -33% | -$3.55M |
|
2415
Vir Biotechnology
VIR
$1.46B
| $7.19M | ﹤0.01% |
165,173
-151,977
| -48% | -$6.58M |
|
2416
Helmerich & Payne
HP
$3.45B
| $7.18M | ﹤0.01% |
+261,980
| New | +$7.31M |
|
2417
Bentley Systems
BSY
$10.8B
| $7.18M | ﹤0.01% |
118,410
+82,410
| +229% | +$5.26M |
|
|
DCRDU
2418
DELISTED
Decarbonization Plus Acquisition Corporation IV Unit
DCRDU
| $7.18M | ﹤0.01% |
+711,242
| New | +$7.16M |
|
2419
CALL
InMode
INMD
$870M
| $7.17M | ﹤0.01% |
90,000
+70,000
| +350% | +$4.27M |
|
2420
Fox Factory Holding Corp
FOXF
$755M
| $7.17M | ﹤0.01% |
49,627
-22,179
| -31% | -$3.41M |
|
|
WAVC.U
2421
DELISTED
Waverley Capital Acquisition Corp. 1 Units, each consisting of one Class A Ordinary Share and one-third of one redeemable warrant
WAVC.U
| $7.17M | ﹤0.01% |
+726,805
| New | +$7.2M |
|
2422
AtaiBeckley Inc
ATAI
$2.66B
| $7.17M | ﹤0.01% |
484,425
-35,061
| -7% | -$570K |
|
2423
AdaptHealth
AHCO
$1.47B
| $7.16M | ﹤0.01% |
307,472
+299,522
| +3,768% | +$7.24M |
|
2424
Energizer
ENR
$1.44B
| $7.16M | ﹤0.01% |
183,360
-331,904
| -64% | -$13.4M |
|
2425
Tower Semiconductor
TSEM
$24.8B
| $7.16M | ﹤0.01% |
239,477
-17,197
| -7% | -$495K |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.